1Thirunavukkarasu C,Yang Y.Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.Br Soc Gastroenterol,2004,53:1010-1019.
3Kahan BD.Potential the rapeutic interventions to avoid or treat chronic allograft dysfunction.Transplantation,2001,71:52.
4Kossakowska AE,Edwards DR,Lee SS,et al.Altered balance between matrix metallo-proteinases and their inhibitors of experimental biliary fibrosis.Am J Pathol,1998,153:1895-1902.
5Kim T,Mars W,Stolzd D,et al.Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration.Hepatology,2000,31:75-82.
1Mennander A,Tiisala S,Halttunen J,et al.Chronic rejection in rat aortic allografts.An experimental model for transplant arteriosclerosis[J].Arterioscler Thromb,1991,11 (3):671-680.
2Mann M J,Gibbons G H,Kernoff R S,et al.Genetic engineering of vein grafts resistant to atherosclerosis[J].Proc Natl Acad Sci U S A,1995,92 (10):4502-4506.
3Shimokawa-Ki K,Katayama M,Matsuda Y,et al.Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma[J].Mol Hum Reprod,2002,8(1):32-36.
4Demetris A J,Zerbe T,Banner B.Morphology of solid organ allograft arteriopathy:identification of proliferating intimal cell populations[J].Transplant Proc,1989,21(4):3667-3669.
5Thirunavukkarasu C,Yang Y,Subbotin V M,et al.Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats[J].Gut,2004,53(7):1010-1019.
6Dambrin C,Klupp J,Birsan T,et al.Sirolimus (rapamycin) monotherapy prevents graft vascular disease in nonhuman primate recipients of orthotopic aortic allografts[J].Circulation,2003,107 (18):2369-2374.
